Skip to content

Clinical trials

Leukemia, Myelomonocytic, Chronic trials in Switzerland

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Myelomonocytic, Chronic Country / region: Switzerland Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20022
20031
20052
20091
20201
20212
20232

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Terminated2
Unknown status2
Active, not recruiting1
Recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
European Organisation for Research and Treatment of Cancer - EORTC6
Novartis Pharmaceuticals3
Children's Oncology Group1
Cogent Biosciences, Inc.1
Janssen Research & Development, LLC1
Prelude Therapeutics1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Myelomonocytic, Chronic13
Myelodysplastic Syndromes10
Leukemia6
Leukemia, Myeloid, Acute6
Myeloproliferative Disorders6
Anemia, Refractory, with Excess of Blasts4
Congenital Abnormalities4
Leukemia, Lymphocytic, Chronic, B-Cell4
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative4
Lymphoma, B-Cell, Marginal Zone4

Trials

Showing 26 to 13 of 13. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.